摘要
青光眼的治疗主要是降低眼压,将眼压控制在不使视神经损害进一步发展的水平。传统抗青光眼手术治疗存在降压效果不稳定、降压时间有限且并发症发生率较高等局限性,这就促成了新型微创青光眼手术方式的出现,如XEN微支架植入术,这一新技术的有效性及安全性在许多临床研究中得以证实,同时也获得了越来越多的关注。为使更多的眼科医生了解XEN微支架植入术,论文通过分析整理近年来与XEN微支架植入术相关的文献并加以概括总结,探讨XEN微支架植入术在青光眼手术中的应用与研究进展。
The major target of glaucoma treatment is lowing intraocular pressure, to prevent further optic nerve damage. The limit of traditional procedures, like the unstable postoperative intraocular pressure and postoperative complications, has contributed to the emergence of a new type of minimally anvasive glaucoma surgery, such as the XEN microstent implantation. The effectiveness and safety of this new technology have been confirmed in many clinical studies and have thus been gaining more attention. To enable ophthalmologists to better understand XEN microstent implantation in glaucoma surgery, this paper summarizes the applications and research progress of XEN microstent implantation in glaucoma surgery by analyzing and summarizing the related literatures on XEN microstent implantation in recent years.
作者
钟煜
廖智敏
段宣初
ZHONG Yu;LIAO Zhimin;DUAN Xuanchu(Department of Ophthalmology,Aier School of Ophthalmology,Central South University/Changsha Aier Eye Hospital/Aier Eye Hospital of Wuhan University,Wuhan 430061,Hubei,China;Department of Ophthalmology,Aier School of Ophthalmology,Central South University/Changsha Aier Eye Hospital,Changsha 410015,Hunan,China)
出处
《山东大学耳鼻喉眼学报》
CAS
2023年第1期145-151,共7页
Journal of Otolaryngology and Ophthalmology of Shandong University
基金
国家自然科学基金(81670859,81970801)
湖南省自然科学基金(2019JJ40001)
长沙市科技局重点研发项目(kh1801229)
湖南省重点领域研发计划资助项目(2020SK2133)
爱尔眼科医院集团科研基金(AR1906D1,AM1906D2)。
关键词
青光眼
XEN微支架
微创青光眼手术
Glaucoma
XEN microstents
Minimally invasive glaucoma surgery